Tariq Ahmad Selected Research

Therapeutics

4/2024	Ischemic Stroke and Reduced Left Ventricular Ejection Fraction: A Multidisciplinary Approach to Optimize Brain and Cardiac Health.
4/2024	Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial.
4/2024	Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.
4/2024	Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
12/2023	Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction.
11/2023	Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib.
11/2023	Clinical Inertia Among Outpatients With Heart Failure: Application of Treatment Nonintensification Taxonomy to EPIC-HF Trial.
10/2023	Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial.
10/2023	Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
9/2023	Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tariq Ahmad Research Topics

Disease

72	Heart Failure 04/2024 - 03/2012
29	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 09/2002
26	Crohn Disease (Crohn's Disease) 04/2024 - 09/2002
12	Ulcerative Colitis 04/2024 - 09/2002
11	Infections 04/2024 - 10/2008
11	COVID-19 10/2023 - 01/2021
8	Inflammation (Inflammations) 02/2024 - 09/2002
7	Cardiomyopathies (Cardiomyopathy) 01/2021 - 07/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 04/2015
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
5	Hemorrhage 01/2021 - 02/2017
5	Myocardial Infarction 01/2021 - 01/2018
5	Stroke (Strokes) 01/2021 - 08/2012
4	Necrosis 03/2024 - 02/2014
4	Breakthrough Infections 10/2023 - 01/2022
4	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 11/2019
4	Fibrosis (Cirrhosis) 10/2017 - 01/2014
3	Atrial Fibrillation 01/2022 - 10/2019
3	Cardiogenic Shock 12/2020 - 10/2019
3	Sarcoidosis (Schaumann Disease) 10/2010 - 10/2002
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 11/2022
2	Obesity 04/2024 - 12/2021
2	Hyperkalemia 10/2023 - 01/2018
2	Hypotension (Low Blood Pressure) 01/2023 - 01/2019
2	Rheumatoid Arthritis 01/2021 - 01/2015
2	Diabetes Mellitus 01/2021 - 01/2018
2	Neoplasms (Cancer) 01/2021 - 04/2016
2	Body Weight (Weight, Body) 01/2021 - 01/2019
2	Ankylosing Spondylitis 01/2021 - 01/2015
2	Weight Loss (Weight Reduction) 01/2020 - 01/2016
2	Acute Coronary Syndrome 01/2019 - 02/2017
2	Systolic Heart Failure 01/2018 - 10/2014
2	Hyponatremia 01/2018 - 01/2016
2	Renal Insufficiency (Renal Failure) 01/2016 - 02/2004
1	Human Influenza (Influenza) 11/2023

Drug/Important Bio-Agent (IBA)

20	Infliximab (Remicade)FDA Link 04/2024 - 09/2002
19	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2012
10	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 06/2014
9	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 12/2012
9	COVID-19 VaccinesIBA 11/2023 - 10/2021
8	VaccinesIBA 10/2023 - 01/2021
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
7	DiureticsIBA 01/2022 - 01/2016
6	Adalimumab (Humira)FDA Link 04/2024 - 11/2015
6	2-mercaptopurineIBA 04/2024 - 10/2014
6	tofacitinibIBA 11/2023 - 12/2019
6	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 01/2014
6	SodiumIBA 01/2022 - 08/2015
5	AntibodiesIBA 10/2023 - 09/2002
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
5	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2018 - 01/2016
4	Phenobarbital (Luminal)FDA Link 04/2024 - 01/2019
4	IntegrinsIBA 01/2023 - 02/2017
4	vedolizumabIBA 01/2023 - 01/2021
4	Galectin 3 (LGALS3)IBA 10/2015 - 10/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 09/2002
3	Immunologic Factors (Immunomodulators)IBA 02/2024 - 12/2020
3	C-Reactive ProteinIBA 02/2024 - 01/2021
3	PotassiumIBA 10/2023 - 01/2018
3	(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptideIBA 10/2023 - 01/2022
3	AntigensIBA 11/2022 - 11/2005
3	Monoclonal AntibodiesIBA 01/2021 - 09/2002
3	Urea (Carbamide)FDA LinkGeneric 01/2020 - 02/2004
3	NitrogenIBA 01/2020 - 02/2004
3	CreatinineIBA 01/2019 - 01/2016
2	oxidized low density lipoproteinIBA 04/2024 - 11/2022
2	LipidsIBA 04/2024 - 11/2022
2	LDL CholesterolIBA 04/2024 - 11/2022
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2024 - 10/2020
2	Janus Kinase InhibitorsIBA 10/2023 - 10/2020
2	Neprilysin (Neutral Endopeptidase)IBA 01/2023 - 01/2022
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2021
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2023 - 01/2022
2	AnthracyclinesIBA 01/2021 - 07/2008
2	Serum AlbuminIBA 01/2021 - 02/2004
2	empagliflozinIBA 01/2021 - 01/2020
2	ReninIBA 01/2020 - 01/2016
2	NucleotidesIBA 09/2017 - 08/2015
2	MicroRNAs (MicroRNA)IBA 09/2017 - 01/2017
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2016 - 10/2014
2	CholesterolIBA 04/2016 - 02/2004
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2016 - 08/2011
2	ChloridesIBA 01/2016 - 08/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2014 - 04/2009
2	Azathioprine (Imuran)FDA LinkGeneric 10/2014 - 04/2009
2	Growth Hormone (Somatotropin)IBA 02/2011 - 01/2006
2	HLA-DRB1 Chains (HLA DRB1)IBA 10/2010 - 09/2002
2	CytokinesIBA 09/2002 - 09/2002
1	Lipid AIBA 04/2024
1	Glycoproteins (Glycoprotein)IBA 10/2023

Therapy/Procedure

62	Therapeutics 04/2024 - 05/2004
10	Heart-Assist Devices 01/2021 - 01/2015
9	Biological Therapy 01/2023 - 09/2002
4	Patient Readmission 01/2021 - 01/2020
3	Ambulatory Care (Outpatient Care) 01/2023 - 09/2017
3	Heart Transplantation (Grafting, Heart) 01/2022 - 09/2019
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 10/2020
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2020
2	Catheters 10/2019 - 01/2017
1	Precision Medicine 04/2024